Search results
Forget Mykonos and Santorini, Syros is the best Greek island. Here are 10 of my favorite things to...
INSIDER via Yahoo News· 1 month agoSyros is a charming Greek island near Mykonos. Joanna Kalafatis Syros, a short ferry ride from...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript November 14, 2023...
individual investors who own 35% along with institutions invested in Syros Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Syros Pharmaceuticals' significant individual investors ownership suggests that the key...
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
Zacks via Yahoo Finance· 6 months agoSyros (SYRS) posts encouraging initial data from the phase II SELECT-AML-1 study evaluating...
Syros Pharmaceuticals, Inc. (SYRS) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) might move higher on growing optimism about its earnings...
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...
Zacks via Yahoo Finance· 1 month agoSyros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a...
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 year agoSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 24.11% and 0.14%,...
Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline...
One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year
Simply Wall St. via Yahoo Finance· 1 year agoViewing insider transactions for Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS ) over the last year, we...
TYME Technologies Shares Surge On Merger Agreement With Syros Pharma
Benzinga via Yahoo Finance· 2 years agoSyros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME),...